June 1, 1998Annals of the New York Academy of Sciences
Diagnosis and Management of Iron‐induced Heart Disease in Cooley's Anemia
Key result
Chronic iron deposition in homozygous beta-thalassemia leads to abnormal cardiac pathology and potentially fatal heart failure, necessitating future trials to explore therapies like ACE inhibitors.
Population
Patients with homozygous beta-thalassemia who are chronically transfused and at risk for iron-induced heart…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Requires vigilant cardiac monitoring in beta-thalassemia; leaves open whether ACE inhibitors prevent iron-induced heart failure.
Structured PICO
P
Population
Patients with homozygous beta-thalassemia (Cooley's Anemia) who are chronically transfused and at risk for iron-induced heart disease.
This review highlights the pathophysiology of iron-induced cardiomyopathy in beta-thalassemia and proposes investigating ACE inhibitors for prevention.
Cite This Study
Jessup et al. (1998) conducted a review in Homozygous beta-thalassemia (Cooley's Anemia). Chronic iron deposition in homozygous beta-thalassemia leads to abnormal cardiac pathology and potentially fatal heart failure, necessitating future trials to explore therapies like ACE inhibitors.